HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N- (4- (3- (1H- 1,2,4- triazol- 1- yl)- 4- (3,4,5- trimethoxybenzoyl)phenyl)thiazol- 2- yl)- 2- amino- 3- methylbutanamide

an antineoplastic agent; a prodrug of S-516; structure in first source
Also Known As:
CKD 516; CKD-516; CKD516
Networked: 16 relevant articles (7 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kim, Soo Jin: 5 articles (01/2020 - 09/2010)
2. Lee, Jeong Min: 5 articles (01/2016 - 10/2013)
3. Choi, Byung Ihn: 4 articles (01/2016 - 10/2013)
4. Han, Joon Koo: 4 articles (01/2016 - 10/2013)
5. Chung, Jin Wook: 3 articles (01/2018 - 04/2014)
6. Kim, Kyung Won: 3 articles (09/2017 - 10/2013)
7. Joo, Ijin: 3 articles (01/2016 - 01/2014)
8. Han, Sae-Won: 2 articles (10/2021 - 01/2016)
9. Kim, Tae-You: 2 articles (10/2021 - 01/2016)
10. Lee, In Joon: 2 articles (01/2018 - 10/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Hepatocellular Carcinoma (Hepatoma)
3. Necrosis
4. Colorectal Neoplasms (Colorectal Cancer)
5. Hypoxia (Hypoxemia)

Related Drugs and Biologics

1. Doxorubicin (Adriamycin)
2. Proteins (Proteins, Gene)
3. Irinotecan (Camptosar)
4. Ethiodized Oil (Ethiodol)
5. Tubulin
6. ErbB Receptors (EGF Receptor)
7. Tubulin Modulators
8. Therapeutic Uses
9. Reactive Oxygen Species (Oxygen Radicals)
10. Carboplatin (JM8)

Related Therapies and Procedures

1. Radiofrequency Ablation
2. Aftercare (After-Treatment)
3. Drug Therapy (Chemotherapy)